Immuneering Corporation is a clinical-stage oncology company that uses computational biology and translational research to develop targeted cancer therapies. Its pipeline focuses on programs for solid tumors and related cancer treatment approaches.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!